Klient: Siemens
Format: Whitepaper
Größe: 4,04 MB
Sprache: Englisch
Datum: 29.07.2026

Mastering oligonucleotide formulations

Optimize Stability. Improve Delivery. Accelerate Development.

Oligonucleotide therapeutics are transforming modern medicine, but developing safe, stable, and effective formulations remains a complex challenge. Achieving the right balance of delivery, stability, manufacturability, and performance is critical for successful drug development. 

This guide explores the latest strategies, technologies, and best practices for optimizing oligonucleotide formulations. Learn how advanced formulation approaches can enhance therapeutic efficacy, reduce development risks, and streamline the path from research to commercialization. 

Download whitepaper to explore proven formulation strategies and discover how to develop stable, effective, and scalable oligonucleotide therapeutics with greater confidence.
Kostenloser Download
Bitte geben Sie Ihre Kontaktdaten ein und klicken Sie auf den Button „Herunterladen“. Sie erhalten dann eine E-Mail mit einem Link zum Herunterladen.

Yes, the sponsor(s) may contact me directly by email or telephone about their products or services. Please refer to the privacy policies of such sponsor(s) for more details on how your information will be used by them and how you can unsubscribe to their communications.

Yes, the sponsor(s) may contact me directly by email or telephone about their products or services. Please refer to the privacy policies of such sponsor(s) for more details on how your information will be used by them and how you can unsubscribe to their communications. 

Yes, Endeavor Business Media may use my contact information consistent with Endeavor's Privacy Policy to communicate with me by email or telephone about other offerings by Endeavor, its brands, affiliates and/or third-party partners that may be of interest to businesses and individual participants in my industry. You may unsubscribe at any time by emailing emailsolutions@endeavorb2b.com.
Mit dem Anklicken des nachstehenden Buttons willigen Sie ein, dass die B2B Media Group GmbH mit ihren verbundenen Unternehmen und Siemens Ihre Daten zu B2B-Marketingzwecken, insbesondere zur marketingbezogenen Kontaktaufnahme per E-Mail und Telefon, verarbeitet und speichert.

Sie können Ihre Einwilligung jederzeit durch eine E-Mail an unsubscribe@b2bmg.com (Betreff: Siemens) widerrufen. Weitere Informationen finden Sie in den Datenschutzhinweisen.

Datenschutz-/Herunterladebedingungen:

Datum: 1.8.2018

Klient

  • B2B Media Group GmbH, Bahnhofstraße 5, 91245 Simmelsdorf (B2B MG)

Partner

  • Siemens
Felder mit * sind Pflichtfelder